Ernexa Therapeutics has introduced a new platform called CEO Corner, where CEO Sanjeev Luther shares deeper insights into the company's scientific strategy, progress, and vision for advancing innovative cell therapies. The platform aims to provide stakeholders with more context beyond typical corporate updates, focusing on scalable, off-the-shelf cell therapies designed to improve accessibility and affordability for patients with advanced cancer and autoimmune diseases. Ernexa’s lead product, ERNA-101, targets ovarian cancer by activating the immune system to fight cancer cells. The CEO Corner is accessible on Ernexa’s website and social media, offering ongoing updates on the company’s mission and development programs.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum rose 3.17% to $1,923.53, outperforming Bitcoin's modest 0.18% gain to $64,588.87, signaling an early rotation toward large-cap altcoins. Despite this, overall market activity slowed, with declines in DeFi, stablecoin, and derivatives trading...
Gabriel Holding A/S has agreed to sell its European FurnMaster furniture manufacturing operations, including subsidiaries in Poland and Lithuania, to Leggett & Platt for an initial price of approximately EUR 9 million, with a possible additional paym...
A Gaza resident raised over £55,000 on GoFundMe to support his family but faced issues as the platform cannot pay directly to Gaza, forcing funds through intermediaries who failed to deliver the full amount. This highlights a broader problem in human...
Crypto investigator ZachXBT criticized all current hardware wallets as insecure and unreliable for signing transactions or storing significant funds. He highlighted Ledger as particularly problematic due to frequent updates that disrupt basic functio...
